KIT exon 11 mutation + KIT exon 17 mutation
|
GIST
|
KIT exon 11 mutation + KIT exon 17 mutation
|
GIST
|
nilotinib Sensitive: C3 – Early Trials
|
nilotinib Sensitive: C3 – Early Trials
|
KIT exon 11 mutation + KIT exon 17 mutation
|
GIST
|
KIT exon 11 mutation + KIT exon 17 mutation
|
GIST
|
sunitinib + IPI 493 Sensitive: D – Preclinical
|
sunitinib + IPI 493 Sensitive: D – Preclinical
|